Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice
- PMID: 2414248
Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice
Abstract
In order to study the cellular immune responses induced by corneal allografts transplanted to a nonimmunologically privileged site, we have used a previously described murine heterotopic corneal allograft model. BALB/c (H-2d) corneal allografts transplanted to a vascular graft bed on the thorax of C57BL/6 (H-2b) recipients were rapidly rejected within 14 days, while corneal syngrafts survived indefinitely (greater than 28 days). Analysis of both primary and secondary cytotoxic T lymphocyte (CTL) responses 7, 10, 14, and 21 days after heterotopic transplantation revealed antigen-specific CTL reactivity at all time points tested (P less than 0.01). By contrast, delayed-type hypersensitivity (DTH) responses to corneal alloantigens (footpad swelling assay) were negative (P greater than 0.05) in 83% of the animals tested. The absence of DTH responsiveness to corneal allografts was not a result of the small graft size or antigenic load. Either two or six circular skin allografts (3-mm diam) of BALB/c origin induced both strong CTL and DTH responses (P less than 0.001) in C57BL/6 recipients, while two or six corneal allografts (2-mm diam) induced strong CTL responses, but DTH responses again failed to develop (P less than 0.05) in over 75% of the animals tested. The ability of corneal alloantigens to elicit CTL responses but not DTH reactivity when grafted to a heterotopic site provides a basis for understanding the immune privilege enjoyed by this tissue.
Similar articles
-
Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.J Immunol. 1986 Jun 15;136(12):4362-71. J Immunol. 1986. PMID: 3519767
-
T cell subsets in the immune rejection of murine heterotopic corneal allografts.Invest Ophthalmol Vis Sci. 1986 Aug;27(8):1244-54. Invest Ophthalmol Vis Sci. 1986. PMID: 2942516
-
T-cell mediated responses in a murine model of orthotopic corneal transplantation.Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1530-40. Invest Ophthalmol Vis Sci. 1995. PMID: 7601633
-
Corneal transplantation--immunologically privileged status.Eye (Lond). 1991;5 ( Pt 5):528-48. doi: 10.1038/eye.1991.96. Eye (Lond). 1991. PMID: 1794420 Review.
-
The immunopathology of intraocular tumour rejection.Eye (Lond). 1991;5 ( Pt 2):186-92. doi: 10.1038/eye.1991.33. Eye (Lond). 1991. PMID: 2070879 Review.
Cited by
-
Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody.Br J Ophthalmol. 1992 Oct;76(10):602-6. doi: 10.1136/bjo.76.10.602. Br J Ophthalmol. 1992. PMID: 1358194 Free PMC article.
-
Leukocyte adhesion molecules in rejected corneal allografts.Graefes Arch Clin Exp Ophthalmol. 1994 Feb;232(2):87-95. doi: 10.1007/BF00171669. Graefes Arch Clin Exp Ophthalmol. 1994. PMID: 7512518
-
Corneal allograft rejection in bilateral penetrating keratoplasty: clinical and laboratory studies.Trans Am Ophthalmol Soc. 1986;84:664-742. Trans Am Ophthalmol Soc. 1986. PMID: 3296407 Free PMC article. No abstract available.
-
Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants.Transplantation. 2009 Jan 15;87(1):16-23. doi: 10.1097/TP.0b013e318191b38b. Transplantation. 2009. PMID: 19136886 Free PMC article.
-
Regional differences in immune regulation: the immunogenic privilege of corneal allografts.Immunol Res. 1988;7(3):247-55. doi: 10.1007/BF02918140. Immunol Res. 1988. PMID: 3057091 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources